Review article
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy
Wang K, Eblan MJ, Deal AM, et al.
DoseLab summary
Pooled analysis of cardiac toxicity after dose-escalated radiotherapy for stage III NSCLC. Citation as given in the eviQ reference list; not yet checked against the journal.
Why this is useful
Pooled analysis linking heart dose to cardiac events after lung radiotherapy; cited for the mean heart dose constraint.
Reference details
- Title
- Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy
- Authors / organization
- Wang K, Eblan MJ, Deal AM, et al.
- Publication / protocol
- J Clin Oncol. 2017;35(13):1387–1394
- Version
- Pending verification
- Year
- 2017
- DOI
- Pending verification
- Disease sites
- Lung
- Topics
- Conventional fractionation, Heart, Toxicity
- Fractionation context
- Conventional (dose-escalation trials)
- Last reviewed by DoseLab
- Pending verification